1.F，l.D.，Mémoire avec une précis de plusieurs observations sur le cancer.Mem Acad Roy Chir Paris， 1757.3：1.

2.J.L.，P.，Oeuvres complétes，sectionⅦ，Limoges，R.Chapoulard.1837.

3.W.S.，H.，The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889to January 1894.Johns Hopkins Hosp Rep，1894-1895.4：297.

4.W.S.，H.，A clinical and histological study of certain adenocarcinomata of the breast.Ann Surg，1898.28：577.

5.R.，V.，Cellular pathology.Frank Chance，translator.London：Churchill；，（1860.）：459-460.

6.Halsted，W.S.，I.The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June，1889，to January，1894.Ann Surg，1894.20（5）：497-555.

7.W.S.，H.，The results of radical operations for cure of cancer of the breast.Ann Surg，1907.46：1.

8.W.S.，H.，Parasternal invasion of the thorax in breast cancer and its suppression by the use of radium tubes as an operative precaution.Surg Gynecol Obstet，1927.45：721.

9.Urban J.A.，B.H.W.，Radical mastectomy in continuity with en bloc resection of the internal mammary lymph chain.Cancer 1952.5：992-1008.

10.O.H.，W.，Discussion to Taylor and Wallace：Carcinoma of the breast，fifty years′experience at the Massachusetts General Hospital.Ann Surg，1950.132：838-843.

11.Patey D.H.，D.W.H.，The prognosis of carcinoma of the breast in relation to the type of operation performed.Br J Cancer，1948.2：7-13.

12.R.，M.，The value of simple mastectomy and radiotherapy in the treatment of cancer of the breast.Br J Radiol，1948.21：599-610.

13.Auchincloss，H.，Significance of Location and Number of Axillary Metastases in Carcinoma of the Breast.Ann Surg，1963.158：37-46.

14.Hirsch.J，Radiumchirurgia des brust Kresbses.Dtsch Med Wochenschr，1927.43：1419-1421.

15.Frank，E.A.，the role of surgery and irradiation in cancer of the breast.JAMA，1943.121（8）：553-559.

16.Mustaizallio，S.，Treatment of Breast Cancer by Tumour Extirpation and Roentgen Therapy Instead of Radical Operation.Journal of the Faculty of Radiologists，1953.7：19-24.

17.Fisher，B.and E.R.Fisher，The interrelationship of hematogenous and lymphatic tumor cell dissemination.Surg Gynecol Obstet，1966.122（4）：791-798.

18.Fisher，B.and E.R.Fisher，The organ distribution of disseminated 51Cr-labeled tumor cells.Cancer Res，1967.27（2）：412-420.

19.Fisher，B.and E.R.Fisher，Studies concerning the regional lymph node in cancer.Ⅰ.Initiation of immunity.Cancer，1971.27（5）：1001-1004.

20.Fisher，B.and E.R.Fisher，Studies concerning the regional lymph node in cancer.Ⅱ.Maintenance of immunity.Cancer，1972.29（6）：1496-1501.

21.Fisher，B.，et al.，Tumor specificity，serum inhibition，and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.Cancer Res，1977.37（10）：3628-3633.

22.Fisher，B.，Biological research in the evolution of cancer surgery：apersonal perspective.Cancer Res，2008.68（24）：10007-10020.

23.Fisher，B.and E.R.Fisher，Experimental evidence in support of the dormant tumor cell.Science，1959.130（3380）：918-919.

24.Fisher，B.，E.R.Fisher，and N.Feduska，Trauma and the localization of tumor cells.Cancer，1967.20 （1）：23-30.

25.Kim，M.Y.，et al.，Tumor self-seeding by circulating cancer cells.Cell，2009.139（7）：1315-1326.

26.Fisher，B.and N.H.Slack，Number of lymph nodes examined and the prognosis of breast carcinoma.Surg Gynecol Obstet，1970.131（1）：79-88.

27.Fisher，B.，et al.，Location of breast carcinoma and prognosis.Surg Gynecol Obstet，1969.129（4）：705-716.

28.Deutsch，M.，et al.，The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy.Results of National Surgical Adjuvant Breast and Bowel Project（NSABP）clinical trials B-04and B-06.Cancer，2003.98（7）：1362-1368.

29.Fisher，B.，et al.，Twenty-five-year follow-up of a randomized trial comparing radical mastectomy，total mastectomy，and total mastectomy followed by irradiation.N Engl J Med，2002.347（8）：567-575.

30.Dewar，J.A.，et al.，Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy（Institut Gustave Roussy 1970-1982）.IGR Breast Cancer Group.Cancer，1995.76（11）：2260-2265.

31.Sarrazin，D.，et al.，Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.Radiother Oncol，1989.14（3）：177-184.

32.Veronesi，U.，Conservative treatment of breast cancer：a trial in progress at the Cancer Institute of Milan.World J Surg，1977.1（3）：324-326.

33.Veronesi，U.，et al.，Comparing radical mastectomy with quadrantectomy，axillary dissection，and radiotherapy in patients with small cancers of the breast.N Engl J Med，1981.305（1）：6-11.

34.Veronesi，U.，et al.，Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.N Engl J Med，2002.347（16）：1227-1232.

35.Fisher，B.，et al.，Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.N Engl J Med，1985.312 （11）：665-673.

36.Lichter，A.S.，et al.，Mastectomy versus breast-conserving therapy in the treatment of stageⅠandⅡcarcinoma of the breast：a randomized trial at the National Cancer Institute.J Clin Oncol，1992.10（6）：976-983.

37.Jacobson，J.A.，et al.，Ten-year results of a comparison of conservation with mastectomy in the treatment of stageⅠandⅡbreast cancer.N Engl J Med，1995.332（14）：907-911.

38.Poggi，M.M.，et al.，Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy：the National Cancer Institute Randomized Trial.Cancer，2003.98 （4）：697-702.

39.Simone，N.L.，et al.，Twenty-five year results of the national cancer institute randomized breast conservation trial.Breast Cancer Res Treat，2012.132（1）：197-203.

40.van Dongen，J.A.，et al.，Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer：EORTC trial 10801，breast conservation compared with mastectomy in TNM stageⅠandⅡbreast cancer.Eur J Cancer，1992.28A（4-5）：801-805.

41.Litiere，S.，et al.，Breast conserving therapy versus mastectomy for stageⅠ-Ⅱbreast cancer：20year follow-up of the EORTC 10801phase 3randomised trial.Lancet Oncol，2012.13（4）：412-419.

42.Gaudette，L.A.，et al.，Declining use of mastectomy for invasive breast cancer in Canada，1981-2000.Can J Public Health，2004.95（5）：336-340.

43.Habermann，E.B.，et al.，Are Mastectomy Rates Really Increasing in the United States？Journal of clinical oncology，2010.28（21）：3437-3441.

44.Beitsch，P.D.，S.F.Shaitelman，and F.A.Vicini，Accelerated partial breast irradiation.J Surg Oncol，2011.103（4）：362-368.

45.Siesling，S.，et al.，Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands，1990-2001.The Breast，2007.16（6）：606-614.

46.Del Turco，M.R.，et al.，Quality indicators in breast cancer care.Eur J Cancer，2010.46（13）：2344-2356.

47.Fukuda，H.，et al.，Change in clinical practice after publication of guidelines on breast cancer treatment.Int J Qual Health Care，2009.21（5）：372-378.

48.Pathy，N.B.，et al.，Breast cancer in a multi-ethnic Asian setting：results from the Singapore-Malaysia hospital-based breast cancer registry.Breast，2011.20Suppl 2：S75-S80.

49.Ahn，S.H.and K.Y.Yoo，Chronological changes of clinical characteristics in 31，115new breast cancer patients among Koreans during 1996-2004.Breast Cancer Res Treat，2006.99（2）：209-214.

50.Suen，D.，L.Chow，and A.Kwong，Breast-conserving surgery in Hong Kong Chinese women.World J Surg，2008.32（12）：2549-2553.

51.张保宁，张斌，唐中华等.中国乳腺癌手术治疗10年的发展与变迁.中华肿瘤杂志，2012.34（08）：582-587.

52.邵志敏，中国抗癌协会乳腺癌诊治指南与规范＿基本要点解读.中国实用外科杂志，2011年10月.31 （11）.

53.Lehman，M.and B.Hickey，The less than whole breast radiotherapy approach.Breast，2010.19（3）：180-187.

54.Buchholz，T.A.，et al.，Radiation use and long-term survival in breast cancer patients with T1，T2primary tumors and one to three positive axillary lymph nodes.Int J Radiat Oncol Biol Phys，2008.71（4）：1022-1027.

55.Fisher，B.，et al.，Twenty-year follow-up of a randomized trial comparing total mastectomy，lumpectomy，and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med，2002.347 （16）：1233-1241.

56.Cabioglu，N.，et al.，Improving local control with breast-conserving therapy：a 27-year single-institution experience.Cancer，2005.104（1）：20-29.

57.Clarke，M.，et al.，Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival：an overview of the randomised trials.Lancet，2005.366 （9503）：2087-2106.

58.Arthur，D.W.and F.A.Vicini，Accelerated partial breast irradiation as a part of breast conservation therapy.J Clin Oncol，2005.23（8）：1726-1735.

59.Vicini，F.A.，et al.，Interim cosmetic results and toxicity using 3Dconformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.Int J Radiat Oncol Biol Phys，2007.69（4）：p.1124-30.

60.Athas，W.F.，et al.，Travel distance to radiation therapy and receipt of radiotherapy following breastconserving surgery.J Natl Cancer Inst，2000.92（3）：269-271.

61.Donovan，E.，et al.，Randomised trial of standard 2Dradiotherapy（RT）versus intensity modulated radiotherapy（IMRT）in patients prescribed breast radiotherapy.Radiother Oncol，2007.82（3）：254-264.

62.Hurkmans，C.W.，et al.，Adaptive radiation therapy for breast IMRT-simultaneously integrated boost：three-year clinical experience.Radiother Oncol.103（2）：183-187.

63.Livi，L.，et al.，Accelerated partial breast irradiation with IMRT：new technical approach and interim analysis of acute toxicity in a phaseⅢrandomized clinical trial.Int J Radiat Oncol Biol Phys.77（2）：509-515.

64.Smith，W.，et al.，IMRT for the breast：a comparison of tangential planning techniques.Phys Med Biol.55 （4）：1231-1241.

65.Veldeman，L.，et al.，Alternated prone and supine whole-breast irradiation using IMRT：setup precision， respiratory movement and treatment time.Int J Radiat Oncol Biol Phys.82（5）：2055-2064.

66.van der Hage，J.A.，et al.，Preoperative chemotherapy in primary operable breast cancer：results from the European Organization for Research and Treatment of Cancer trial 10902.J Clin Oncol，2001.19 （22）：4224-4237.

67.Rastogi，P.，et al.，Preoperative chemotherapy：updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18and B-27.J Clin Oncol，2008.26（5）：778-785.

68.Powles，T.J.，et al.，Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.J Clin Oncol，1995.13（3）：547-552.

69.Gianni，L.，et al.，Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide，methotrexate，and fluorouracil and its effects on tumor response as preoperative therapy.Clin Cancer Res，2005.11（24Pt 1）：8715-8721.

70.Fisher，B.，et al.，Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer：findings from National Surgical Adjuvant Breast and Bowel Project B-18.J Clin Oncol，1997.15（7）：2483-2493.

71.Bear，H.D.，et al.，Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer：National Surgical Adjuvant Breast and Bowel Project Protocol B-27.J Clin Oncol，2006.24（13）：2019-2027.

72.Morrow，M.，Magnetic resonance imaging for screening，diagnosis，and eligibility for breast-conserving surgery：promises and pitfalls.Surg Oncol Clin N Am，2010.19（3）：475-492.

73.Rebner，M.，I.Grills，and F.Vicini，Should screening MRI be included in surveillance for patients treated with breast-conserving therapy？Nat Clin Pract Oncol，2009.6（1）：8-9.

74.Walsh，P.M.，et al.，Influence of mammographic screening on trends in breast-conserving surgery in Ireland.Eur J Cancer Prev，2006.15（2）：138-148.

75.Fisher，B.，et al.，Five versus more than five years of tamoxifen for lymph node-negative breast cancer：updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14randomized trial.J Natl Cancer Inst，2001.93（9）：684-690.

76.Fisher，B.，et al.，Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors：eight-year results from National Surgical Adjuvant Breast and Bowel Project（NSABP）B-13and first report of findings from NSABP B-19comparing methotrexate and fluorouracil with conventional cyclophosphamide，methotrexate，and fluorouracil.J Clin Oncol，1996.14（7）：1982-1992.

77.Romond，E.H.，et al.，Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.N Engl J Med，2005.353（16）：p.1673-1684.

78.Pierce，L.J.，et al.，Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stageⅠ/Ⅱbreast cancer.J Clin Oncol，2006.24（16）：2437-2443.

79.Haffty，B.G.，et al.，Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.Lancet，2002.359（9316）：1471-1477.

80.Lam，W.W.，et al.，Surgeon′s recommendation，perceived operative efficacy and age dictate treatment choice by Chinese women facing breast cancer surgery.Psychooncology，2005.14（7）：585-593.

81.Mac Bride，M.B.，et al.，Factors associated with surgical decision making in women with early-stage breast cancer：a literature review.J Womens Health（Larchmt），2013.22（3）：236-242.

82.Liu，J.J.，et al.，Breast-conserving therapy versus modified radical mastectomy：socioeconomic status determines who receives what--results from case-control study in Tianjin，China.Cancer Epidemiol，2012.36（1）：89-93.

83.Mastaglia，B.and L.J.Kristjanson，Factors influencing women′s decisions for choice of surgery for Stage Ⅰand StageⅡbreast cancer in Western Australia.J Adv Nurs，2001.35（6）：836-847.

84.Gumus，M.，et al.，Factors that Affect Patients′Decision-Making about Mastectomy or Breast Conserving Surgery，and the Psychological Effect of this Choice on Breast Cancer Patients.Breast Care（Basel），2010.5（3）：164-168.

85.Caldon，L.J.，et al.，Case-mix fails to explain variation in mastectomy rates：management of screen-detected breast cancer in a UK region 1997-2003.Br J Cancer，2005.92（1）：55-59.

86.White，V.，et al.，The management of early breast carcinoma before and after the introduction of clinical practice guidelines.Cancer，2004.101（3）：476-485.

87.Pappo，I.，et al.，Breast cancer in the elderly：histological，hormonal and surgical characteristics.Breast，2007.16（1）：60-67.

88.Martin，M.A.，et al.，Mastectomy or breast conserving surgery？Factors affecting type of surgical treatment for breast cancer-a classification tree approach.BMC Cancer，2006.6：98.

89.Staradub，V.L.，et al.，Factors that influence surgical choices in women with breast carcinoma.Cancer，2002.95（6）：1185-1190.

90.Adkisson，C.D.，et al.，Patient age and preoperative breast MRI in women with breast cancer：biopsy and surgical implications.Ann Surg Oncol，2011.18（6）：1678-1683.

91.Moreland，A.，et al.，Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer.Am J Surg，2009.198（6）：787-791.

92.Ridao-Lopez，M.，et al.，Income level and regional policies，underlying factors associated with unwarranted variations in conservative breast cancer surgery in Spain.BMC Cancer，2011.11：145.

93.Katipamula，R.，et al.，Trends in mastectomy rates at the Mayo Clinic Rochester：effect of surgical year and preoperative magnetic resonance imaging.J Clin Oncol，2009.27（25）：4082-4088.

94.Morrow，M.，et al.，Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.JAMA，2009.302（14）：1551-1556.

95.Garcia-Etienne，C.A.，et al.，Mastectomy trends for early-stage breast cancer：a report from the EUSOMA multi-institutional European database.Eur J Cancer，2012.48（13）：1947-1956.

96.Sepucha，K.，et al.，An approach to measuring the quality of breast cancer decisions.Patient Educ Couns，2007.65（2）：261-269.

97.Collins，E.D.，et al.，Can women with early-stage breast cancer make an informed decision for mastectomy？J Clin Oncol，2009.27（4）：p.519-25.

98.Waljee，J.F.，M.A.Rogers，and A.K.Alderman，Decision aids and breast cancer：do they influence choice for surgery and knowledge of treatment options？J Clin Oncol，2007.25（9）：1067-1673.

99.Tassin，S.，et al.，［Psychosocial aspects of breast cancer］.Rev Med Liege，2011.66（5-6）：315-319.

100.Chopra，I.and K.M.Kamal，A systematic review of quality of life instruments in long-term breast cancer survivors.Health Qual Life Outcomes，2012.10：14.

101.Moyer，A.，Psychosocial outcomes of breast-conserving surgery versus mastectomy：a meta-analytic review.Health Psychol，1997.16（3）：284-298.

102.Ganz，P.A.，et al.，Quality of life at the end of primary treatment of breast cancer：first results from the moving beyond cancer randomized trial.J Natl Cancer Inst，2004.96（5）：p.376-387.

103.Rowland，J.H.，et al.，Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors.J Natl Cancer Inst，2000.92（17）：1422-1429.

104.Nissen，M.J.，et al.，Quality of life after breast carcinoma surgery：a comparison of three surgical procedures.Cancer，2001.91（7）：1238-1246.

105.Harcourt，D.M.，et al.，The psychological effect of mastectomy with or without breast reconstruction：aprospective，multicenter study.Plast Reconstr Surg，2003.111（3）：1060-1068.

106.Engel，J.，et al.，Quality of life following breast-conserving therapy or mastectomy：results of a 5-year prospective study.Breast J，2004.10（3）：223-231.

107.Ward，S.，S.Heidrich，and W.Wolberg，Factors women take into account when deciding upon type of surgery for breast cancer.Cancer Nurs，1989.12（6）：344-351.

108.Ganz，P.A.，et al.，Quality of life in long-term，disease-free survivors of breast cancer：a follow-up study.J Natl Cancer Inst，2002.94（1）：39-49.

109.Parker，P.A.，et al.，Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer.Ann Surg Oncol，2007.14（11）：3078-3089.

110.Arora，N.K.，et al.，Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma：aprospective study.Cancer，2001.92（5）：1288-1298.

111.Carver，C.S.，et al.，Quality of life among long-term survivors of breast cancer：Different types of antecedents predict different classes of outcomes.Psychooncology，2006.15（9）：749-758.

112.Antoni，M.H.and S.Lutgendorf，Psychosocial factors and disease progression in cancer.Current Directions in Psychological Science，2007.16（1）：42-46.

113.Andersen，B.L.，et al.，Stress and immune responses after surgical treatment for regional breast cancer.J Natl Cancer Inst，1998.90（1）：30-36.

114.Patil，R.，et al.，Clinical and immunologic responses of HLA-A3+breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine，E75，in a phaseⅠ/Ⅱclinical trial.J Am Coll Surg，2010.210（2）：140-147.

115.Manfred Schedlowski，C.J.，Giesela Schimanski，Uwe Tewes，Hans-Joachim Schmoll，Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients.Psycho-Oncology，1994.3（3）：181-187.

116.van der Pompe，G.，et al.，Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients：an exploratory study.J Psychosom Res，1997.42（5）：453-466.

117.Blomberg，B.B.，et al.，Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery：An exploratory study.J Psychosom Res，2009.67（5）：369-376.

118.Dhabhar，F.S.and B.S.McEwen，Enhancing versus suppressive effects of stress hormones on skin immune function.Proc Natl Acad Sci U S A，1999.96（3）：1059-1064.

119.Dhabhar，F.S.，Stress-induced augmentation of immune function-the role of stress hormones，leukocyte trafficking，and cytokines.Brain Behav Immun，2002.16（6）：785-798.

120.Waljee，J.F.，et al.，Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life.J Clin Oncol，2008.26（20）：3331-3337.